• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

Anti-HIV drug now indicated to treat chronic hepatitis B


Chronic hepatitis B can now be treated with a new drug.

Key Points

Known as the silent killer because it can persist for years without showing symptoms, chronic hepatitis B can now be treated with a new drug. Gilead Sciences' Viread (tenofovir disoproxil fumarate) was approved in 2001 to treat HIV. Chronic hepatitis B is a liver disease that disproportionately affects Asian Americans and is the leading cause of liver cancer worldwide. Complications from the disease can kill one in four of those affected.

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2023 MJH Life Sciences

All rights reserved.